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Abstract
Background: While conventional cloning methods using restriction enzymes and polynucleotide
ligase are adequate for most DNAs, fragments made by the polymerase chain reaction are difficult
to clone because the amplifying DNA polymerase tends to add untemplated nucleotides to the 3'-
termini of the amplified strands. Conservative site-specific recombinases offer an efficient
alternative to conventional cloning methods.
Results: In this paper I describe the use of the Flp site-specific recombinase for cloning PCR-
amplified fragments. A DNA fragment is amplified with primers that contain at their ends inverted
target sequences for Flp. Flp readily recombines these fragments in vitro into a vector that also
contains two inverted Flp target sequences surrounding the α-complementing region of the lacZ
gene of E. coli. The recombinants are conveniently detected as white colonies by the familiar blue/
white screening test for lacZ activity. A useful feature of the system is that both orientations of the
inserted DNA are usually obtained. If the recipient vector is cut between the two inverted Flp
targets, Flp "heals" the double-strand break by inserting a linear fragment flanked by Flp targets.
Conclusion: This system ("The Flp Double Cross System") should be useful for cloning multiple
PCR fragments into many sites in several vectors. It has certain advantages over other available
recombinase-based cloning procedures.
Background
Cloning of DNA fragments is usually done by cleaving
DNA and a vector with restriction enzymes, ligating the
DNA molecules together and screening transformed bac-
teria for the desired recombinants [1]. The advent of the
polymerase chain reaction (PCR) has facilitated the
amplification of any piece of DNA whose sequence is at
least partly known [2]. It is often desirable to clone
directly a PCR fragment but because the amplifying DNA
polymerase frequently adds extra residues to the 3' ter-
mini [3,4], one must commonly cut the fragment with a
restriction enzyme or clone it into a special vector that
contains protrusions that are complementary to the
extended termini on the PCR fragment.
Conservative site-specific recombinases catalyze rear-
rangements of DNA at specific sequences [5–7]. They
cleave and covalently attach to their target sites (for exam-
ple, the Flp recognition target, FRT site, see Fig. 1a) and
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a). The structure of the FRT site. The FRT site consists of three 13 bp symmetry elements (horizontal arrows, a, b, and c, red 
letters) to which Flp binds in a site-specific manner. The 'a' and 'b' elements are in inverted orientation while the 'b' and 'c' ele-
ments are in direct orientation. The 'c' element is dispensable for recombination function but was included in all the substrates 
used here. The 'a' and 'b' elements are separated by an 8 bp asymmetric core region (open box, blue letters) across which 
recombination takes place. The vertical arrows indicate the two cleavage sites [24]. Flp makes a pair of staggered breaks at 
these sites, covalently attaching itself to the 3'-phosphoryl C residue at each site via the catalytic tryosine, residue no. 343[7]. 
b). General strategy for Flp double cross cloning. The receptor plasmid has the lacZ cassette flanked by inverted FRT sites. The 
gene of interest is PCR-amplified with primers that also contain inverted FRT sites at their ends. Flp promotes a double cross-
over and replaces the lacZ cassette with the gene of interest. The receptor plasmid (left) causes its host bacterium to make a 
blue colony when plated on the indicator dye X-Gal. The desired plasmid (right) causes a white colony. Because the FRT sites 
are in inverse orientation, the gene of interest is not cut out. Rather Flp inverts its orientation so that both orientations are 
usually obtained.Page 2 of 10
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and very high efficiency.
Members of the integrase family of recombinases such as
Cre of phage P1 and Flp of the yeast 2 µM plasmid have
been extensively used in vivo to engineer the genomes of
several organisms [8,9]. Such tools have been powerful
adjuncts to the study of development. Recently, members
of the Integrase family have also been used for cloning
DNA fragments in vitro [10,11]. While efficient, these sys-
tems require the prior construction of vectors and genetic
selections to remove undesired products.
I describe here an in vitro system in which PCR fragments
bearing two inverted targets of the Flp recombinase (FRT
sites) are recombined by the Flp protein into a vector that
also contains two inverted FRT sites. Bacterial colonies
containing the desired recombinants can be readily iden-
tified using the familiar blue/ white screening technique
for the presence or absence of β-galactosidase [12,13].
Results
Rationale of the cloning system
I sought to develop a procedure that would facilitate the
cloning of many PCR fragments into any vector. Commer-
cially available systems [14] depend upon the availability
of the particular vector from the supplier.
The present system (Fig. 1b) requires only that the user
clones into the desired target site a receptor cassette that
a) Strategy for cloning the lacZ fragment into pBA128Figure 2
a) Strategy for cloning the lacZ fragment into pBA128. The PCR-amplified lacZ fragment containing terminal inverted FRT sites 
is incubated with plasmid pBA128 and Flp. After transformation of XL1-Blue competent cells, the DNA from blue colonies is 
analyzed by EcoRI enzyme digestion. Colonies containing the parent pBA128 plasmid are white in color (left) whereas the 
p128lacZ transformants are blue (right).Page 3 of 10
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alpha-complementing N-terminus of the beta
galactosidase gene surrounded by two inversely oriented
FRT sites. Bacterial colonies containing the receptor vector
stain blue in the presence of X-Gal dye [12,15]. One then
amplifies the desired fragment with primers that contain
terminal inversely oriented FRT sites. Flp catalyzes an effi-
cient double crossover event between the PCR fragment
and the receptor lacZ cassette causing replacement of the
latter with the PCR fragment. The DNA is used to trans-
form a suitable host and the colonies containing the
recombinant clones are white when plated in the presence
of X-Gal. A secondary benefit of this procedure derives
from the fact that the FRT sites are in inverse orientation;
once the fragment is inserted, Flp cannot cut it out again
although it can readily invert it so that one will usually
obtain the desired fragment cloned in both orientations
[7]. This is in contrast to several cloning systems that rely
upon the (reversible) formation of recombinase-catalyzed
replicon fusions.
Cloning of the lacZ FRT cassette into plasmid pBA128
In order to create a test plasmid, I used PCR primers 1 and
2 (Table 1) to amplify a 398 bp sequence of the E. coli lac
operon. In addition to the lac sequences, the primers con-
tained two inversely oriented, 48 bp FRT sites as well as 23
nucleotides of 'buffer' sequence at their 5' termini. These
buffer sequences contained three restriction enzyme rec-
ognition sequences (AscI, SalI and NdeI) to facilitate con-
ventional cloning into other vectors although they were
not used here. Primers 1 and 2 also contained a BamHI
and an EcoRI recognition site, respectively located 3' to
the FRT sites to facilitate the determination of the orienta-
tion of the insert. This 592 bp fragment is called the
"lacZ(FRT)2 cassette".
To create a test receptor plasmid molecule I used Flp itself
to recombine the lacZ(FRT)2 cassette into plasmid
pBA128 (Fig. 2a). This pUC9-based plasmid contains two
inversely oriented FRT sites 667 bp apart (Brenda J.
Andrews, unpublished). I incubated pBA128 DNA (100–
1000 ng, 15–150 nM of symmetry elements), the
lacZ(FRT)2 cassette (100 ng, 100 nM symmetry elements)
and purified Flp protein (140 ng, 200 nM) together. The
recombinant plasmids changed the color of the colonies
containing them from white to blue. Flp catalyzed the
appearance of blue colonies that was dependent upon the
presence of the lacZ(FRT)2 cassette. No blue colonies were
obtained in the absence of the cassette or in the absence
of Flp (data not shown). The frequency of blue colonies
varied between 1 and 10%, depending on the relative con-
centrations of the vector and the fragment. One µg of vec-
tor yielded 42 blue colonies (2790 colonies total; 1.5%)
whereas 100 ng of vector gave 55 blue out of 570 total col-
onies (9.6%). Restriction analysis showed that DNA iso-
lated from blue colonies had the pattern expected of a Flp-
mediated insertion of the lacZ(FRT)2 cassette, creating
plasmid "p128lacZ" (data not shown). Furthermore the
lacZ(FRT)2 cassette was inserted in both orientations with
equal frequency. The plasmid DNA isolated from white
colonies was the expected parental pBA128 DNA.
Although I used Flp to clone the lacZ(FRT)2 cassette into
the pBA128 vector, the cassette can also readily be cloned
into any suitable restriction site in any vector by conven-
tional techniques. After transformation of a suitable host,
the desired blue colonies are easily identified.
Use of p128-lacZ plasmid for cloning of other PCR 
fragments
In order to show that the p128lacZ plasmid could serve as
a receptor for other PCR fragments, I amplified a 1.5 Kb
fragment of human DNA from the intron 10 of the
KCNQ1 gene on chromosome 11. Recombination of this
fragment into p128lacZ was expected to create the two iso-
forms (See Fig. 3a). The primers also contained the same
Table 1: PCR primers used in this study
# Primer name Primer sequence (5'-3') Features Amplifies
1. FRT 5' (Bam) 
LacZ
tcaggcgcgccgtcgaccatatg gaagttcctatac tttctaga gaataggaacttc g gaataggaacttc 
GGATCC caaaccgcctctccccgcgc
Buffer sequence FRT site 
BamHI site lac sequence 97 
nt
591 bp of lac promoter, operator 
and lacZ (including primers). 5' end 
begins at nt# 1081 of J01636 
(GI146575)
2. FRT inverse 3' 
(RI) LacZ
catggcgcgccgtcgaccatatg gaagttcctatac tttctaga gaataggaacttc g gaataggaacttc 
GAATTC ccggaaaccaggcaaagcg
Buffer sequence FRT site 
EcoRI site lacZ sequence 96 
nt
591 bp of lac promoter, operator 
and lac Z (including primers). 5' 
end begins at nt# 1479 of J01636 
(GI146575)
3. FRT 5' (Bam) 
KvDMR
tcaggcgcgccgtcgaccatatg gaagttcctatac tttctaga gaataggaacttc g gaataggaacttc 
GGATCC agtgggggcttcagaacatc
Buffer sequence FRT site 
BamHI site KvDMR 
sequence 97 nt
1679 bp of intron 10 of human 
KCNQ1 gene(including primers). 
5'end begins at nt #68364 of acces-
sion # U90095
4. FRT inverse 3' 
(RI) KvDMR
catggcgcgccgtcgaccatatg gaagttcctatac tttctaga gaataggaacttc g gaataggaacttc 
GAATTC gattccagactccaatccca
Buffer sequence FRT site 
EcoRI site KvDMR sequence 
97 nt
1679 bp of intron 10 of human 
KCNQ1 gene (including primers). 
5'end begins at nt #66879 of acces-
sion # U90095Page 4 of 10
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cassette (primers 3 and 4, Table 1).
Analysis of the DNA from 8 white colonies obtained from
the incubation with the KCNQ1 fragment showed that 6
of them contained an insert of the expected 1.6 Kb size
when the DNA was cut with XbaI, an enzyme that cuts
within the FRT sites (Fig. 3b, lanes 2, 3, 4, 6, 7, 9). The fre-
quency of white colonies for this fragment was about 1%.
Furthermore I confirmed by digestion with EcoRI that the
experiment yielded approximately equal numbers of each
orientation of the insertions (2 'A' isolates {Fig. 3c, lanes
3 and 6} and 4 'B' isolates {Fig. 3c, lanes 2, 4, 5, 7}. These
experiments show that Flp can recombine a PCR fragment
containing inverted FRT sites into a receptor vector con-
taining an indicator lacZ(FRT)2 cassette. A simple and
familiar color screen yields a high frequency of recom-
binants in both orientations.
Use of linear receptor vector containing inverted FRT sites
It is well known that linearizing a circular DNA plasmid
markedly reduces its efficiency of transformation of bacte-
ria. It seemed possible that a linear plasmid containing
two inverted FRT sites, one at each end, might be "healed"
by a double crossover between the plasmid and a linear
fragment catalyzed by Flp. The result would be a circular
plasmid containing the insert identical to the fragment. I
therefore linearized plasmid pBA128 by cutting it
between the two inverted FRT sites with PstI (Fig. 4a). The
plasmid was then incubated in the presence of the
lacZ(FRT)2 cassette and Flp and the DNA was used to
transform XL1-Blue competent E. coli cells. There was a
large increase in the proportion of blue colonies that was
dependent upon Flp and the presence of the lacZ(FRT)2
cassette (Table 2). Linearization of the plasmid caused a
30-fold decrease in the transformation efficiency. Flp sig-
nificantly reduced the transformation efficiency further,
an effect that was mitigated by inclusion of the lacZ(FRT)2
cassette in the reaction. This may have been due to the
presence of exonuclease in the Flp preparation although
the reactions were done in the absence of divalent metal.
Furthermore, highly purified homogeneous Flp gave the
same results. Importantly inclusion of the lacZ cassette in
the reaction with Flp caused the appearance of greater
than 50% of blue colonies. The appearance of blue colo-
nies was dependent on inclusion of the lacZ cassette in the
reaction (Table 2) and on the inclusion of Flp in the reac-
tion (data not shown). The latter experiment excludes the
possibility that the recombinants are being formed in E.
coli in vivo.
To confirm that the transformants contained plasmids
with the expected structure, I isolated DNA from 5 blue
colonies and subjected it to digestion with XbaI and EcoRI.
The results showed that all 5 of 5 blue colonies assayed
contained DNA that gave the expected patterns of diges-
tion for insertion of the lacZ(FRT)2 cassette (Figure 4a). As
seen in Fig. 4b, all 5 isolates showed the expected 500 bp
band upon digestion with XbaI (lanes 4–8). Furthermore
the lacZ(FRT)2 cassette was inserted in both orientations
(Fig 4c, 'A' orientation lanes 4, 7; 'B' orientation, lanes 5,
6, 8). Similar results were obtained with two other linear
plasmids that contained a cloned KCNQ1 cassette (data
not shown).
Discussion
Advantages of Flp Double cross System
In this paper I describe a simple cloning procedure that
uses Flp to recombine fragments of DNA that contain
inverted FRT sites into a receptor vector that contains
similarly oriented FRT targets. These FRT sites flank a cas-
sette that imparts a color to transformant colonies, in this
case the alpha-complementing fragment of lacZ that
imparts a blue color. The system has several advantages
over present cloning strategies, especially for the cloning
of multiple PCR fragments into the same site of a vector.
Firstly, because of the high specificity and simple require-
ments of Flp, the reaction is highly efficient. Since con-
servative site-specific recombinases like Flp attach
covalently to their DNA substrate via a hydoxylated
amino acid (tyrosine for members of the integrase family)
no high-energy cofactor such as ATP is required. Further-
more Flp performs its reactions without the need for
accessory factors such as those required by the lambda
integrase (the host-coded IHF and the phage-coded Xis
[6].
Secondly, Flp catalyzes intramolecular excision or inver-
sion reactions on DNA molecules containing two FRT
sites as well as intermolecular reactions between mole-
cules containing FRT sites [7]. The system described here
uses the ability of Flp to catalyze two intermolecular reac-
tions (or perhaps one intermolecular reaction followed by
an intramolecular reaction) and thereby to insert a frag-
ment into the receptor plasmid. Once the double
crossover has occurred, Flp cannot excise the insert from
the plasmid because the FRT sites are in inverted orienta-
tion. A useful feature of this system is that Flp efficiently
will invert the insert between the FRT sites with the result
that one almost always obtains both orientations of the
insertion. This can be very helpful in examining the orien-
tation-dependence of a cis-acting sequence or in generat-
ing sense and antisense RNA probes.
Thirdly, the Flp double cross system is simple in concept
and in execution. It uses the familiar blue-white screening
technique to identify the desired recombinant clones. It is
therefore adaptable to the cloning of any fragments into
any site in any vector. The prerequisites are the construc-
tion of a single vector that contains the PCR-amplifiedPage 5 of 10
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a). Cloning of a 1.65 Kb fragment of human DNA into receptor plasmid p128lacZ. Schematic diagram. A 1.65 Kb fragment from 
intron 10 of the human KCNQ1 gene (dashed arc) was amplified using the primers 3 and 4 and subjected to Flp double cross 
cloning into receptor plasmid p128lacZ. The resultant recombinants transform XL1-Blue cells to form white colonies (right). 
The KCNQ1 fragment replaces the lacZ cassette in either orientation. In the 'A' orientation EcoRI digestion yields a 118 bp 
fragment while in the 'B' orientation a 1.65 Kb fragment is seen. b) Agarose gel analysis of DNA isolated from white colonies 
after Flp double cross cloning of KCNQ1 fragment into 128lacZ receptor plasmid. XbaI. Six of the plasmids from 8 white colo-
nies (lanes 2–4, 6, 7 and 9) show the expected 1.6 Kb fragment. Lane 1-plasmid pBA128; lane 10-marker DNAs (M, 1 
Kb+marker DNA). c) The DNAs shown in b were then digested with EcoRI (1anes 1–9). Lanes 2–7 show the same DNAs as in 
panel b) from lanes 2, 3, 4, 6, 7, 9. Four of them show a 1.5 Kb fragment diagnostic of the B form of the plasmid (lanes 2, 4, 5, 
7,) whereas the DNA from two of the six is in the A form (lanes 3 and 6,). The 118 bp fragment cannot be seen on this gel. 
Lane 9-1Kb+ marker DNAs.Page 6 of 10
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Flp double cross cloning into a linear vector. a) Cloning of the lacZ cassette into linear pBA128 plasmid. The plasmid is linear-
ized with PstI and incubated in the presence of the lacZ cassette and Flp (left). Flp catalyzes the insertion of the lacZ cassette 
into the linear vector forming a circular p128lacZ derivative (right). The insertion takes place in either orientation with the for-
mation of the A and B isoforms. Colonies harboring the desired plasmids are blue when plated in the presence of X-Gal. The 
two isoforms can be distinguished by digestion with EcoRI. b. Agarose gel electrophoretic analysis of DNA from Flp double 
cross cloning of lacZ cassette into linear vectors. The lacZ cassette was incubated with linear pBA128 DNA (lanes 2–8). The 
DNA resulting from transformation of competent XL1-Blue cells was digested with XbaI. The DNAs in corresponding lanes 
shown in panels b) and c) were isolated from the same colony. M-1Kb+ marker DNAs. Blue colonies (B) all showed a 512 bp 
band diagnostic of insertion of the lacZ cassette (lanes 4–8) whereas the white colony (W) did not (lane 3). The parent plasmid 
(P, pBA128, lane2) showed band of 672 bp. c) EcoRI digestion. The isolates in lanes 5, 6, 8, showed the 512 bp band indicative 
of the 'B' orientation whereas those in lanes 4, and, 7 showed no such band since the 118 bp, indicative of the 'A' orientation 
band was not visible in this gel. Note however that the top vector band is migrating more slowly than those DNAs having the 
'B' orientation. P-parental DNA was pBA128 (lane2) digested with EcoRI.Page 7 of 10
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of Flp. The receptor vector can be used to clone many frag-
ments that have been amplified using primers containing
terminal FRT sites. Although Flp is not available commer-
cially and is not produced abundantly in E. coli when his-
tidine-tagged (A. Shaikh and P.D. Sadowski,
unpublished), nevertheless, ample amounts for the clon-
ing method described here can be made in a 2-column
procedure [16]. A two-column procedure for purifying
His-tagged mutant Flpe protein was recently described
[17].
Comparison with Other Recombinase-based Cloning 
Systems
The Flp double cross system has advantages over currently
available cloning systems that use site-specific recombi-
nases or topoisomerase. The Gateway™ cloning system of
Invitrogen [10] uses the lambda integrase reaction to
transfer a gene of interest flanked by attL sites from an
"entry clone" into a "destination vector". While elegant in
its design, this system may be conceptually difficult for the
non-expert to understand. Furthermore it requires the
prior construction of the entry clone by the user and
depends on the availability of the appropriate destination
vector from the vendor. The Flp system is simple to under-
stand and to execute and requires only the construction of
a single receptor vector by the user.
Invitrogen and Clontech also sell a Cre-based cloning sys-
tem (The Echo™ Cloning System and the Creator™ Gene
Cloning and Expression System, respectively). Both
require the construction of donor vectors, the purchase of
acceptor vectors and genetic selections because of the
ready reversibility of the Cre reactions. The Flp double
cross system circumvents the reversibility problem by
using two inverted FRT sites. Because of the high effi-
ciency, a simple color screen suffices to detect the desired
recombinants. Invitrogen also markets the TOPO® Clon-
ing System [14] that uses a vector containing topoisomer-
ase that is covalently attached to ligate the PCR fragment
to the vector. While highly efficient, it depends on the
availability of the appropriate topoisomerase-containing
vectors from the vendor.
Improvements to the System
In the present experiments I used primers that contained
the full 48 bp sequence of the FRT site flanked by 23
nucleotides of 'buffer' sequence. Thus the PCR primers are
rather long and hence expensive. It is likely that the prim-
ers could be substantially shortened by deleting the buffer
sequences and/or the 'c' symmetry element. It is well
known that the third 13 bp symmetry element ('c', See Fig.
1a) is not needed for efficient recombination by Flp in vivo
and in vitro [18,19]. The FRT site contains a near-perfect
13 bp palindrome, (the a and b symmetry elements, Fig-
ure 1a) which may cause unpredicted effects when the
vector is used. Control experiments are needed to exclude
such effects that may be attributable to the FRT sites. A
detailed study of the importance of each position in the
symmetry elements to the Flp recombination reaction has
been carried out [20]. It should be possible using these
studies as well as the recent co-crystal structure of Flp and
the FRT site [21] to design FRT sites that would be func-
tional and yet not interfere with translation or other proc-
esses. Likewise it should be possible to design a functional
FRT site that is not palindromic. A selection system for Flp
variants with altered FRT site specificity has recently been
described [22]. Directional insertions could also be
achieved using directly oriented FRT sites that have non-
homologous spacer regions.
Although I chose the lacZ α-complementation system as
the indicator because of its familiarity and convenience,
other indicator systems are possible. For example, I ampli-
fied a PCR fragment containing the green fluorescent pro-
tein [23] driven by the lac promoter and flanked by
inverted FRT sites. Flp recombined this fragment into the
pBA128 vector. The recombinants were easily detected as
green fluorescent colonies under long-wavelength ultravi-
olet light. However the green fluorescent protein
Table 2: Flp cloning using linear plasmid DNA*
Addition/reaction 1 2 3 4
Circular pBA128 +
Linear pBA128 - + + +
Lac Z cassette - - - +
Flp - - + +
Colonies/µg 6 × 107 1.8 × 106 1.5 × 104 3 × 105
% blue colonies 0 0 0 56%
*The reactions (10 µl) contained 100 ng of the indicated plasmid DNA, and where indicated, 100 ng of the purified lacZ cassette and 130 ng of S300 
fraction of Flp. The reactions were processed as described in the Methods and 1 µl aliquots were used to transform competent XL1-blue E. coli 
cells (Stratagene). Transformed cells were plated on LB agar plates containing ampicillin, IPTG and X-Gal as described in the Methods.Page 8 of 10
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E. coli cells. Further experiments are being done with this
system. In developing the test system I made extensive use
of the lacZ(FRT)2 cassette that functioned rather effi-
ciently. It is my experience that different PCR fragments
recombined with different efficiencies. For example the
KCNQ1 fragment, which is a part of CpG island from
human DNA did not recombine as efficiently as the
lacZ(FRT)2 cassette. The reasons for the variability in clon-
ing efficiencies are being investigated.
Conclusion
The present paper describes a simple and efficient cloning
strategy using the Flp recombinase. The method has cer-
tain advantages over currently available commercial
procedures and may be extended to other recombinases;
it could be applied in vivo. The vectors and Flp protein
used in this paper are available from the author.
Methods
Media and growth conditions
Bacteria were grown in LB medium supplemented with
100 µg per ml of ampicillin according to standard meth-
ods [1]. Competent E. coli XL1-Blue cells (recA1 endA1
gyrA96 thi-1 hsdR17 supE44 relA1 lac [F' proAB lacIq Z∆M15
Tn10 (Tetr)]) were purchased from Stratagene (La Jolla,
CA, USA, cat. # 200249). Transformation and staining
colonies for beta galactosidase with X-Gal were done
according to the manufacturer's instructions.
DNA isolation
Plasmid pBA128 is a derivative of plasmid pBA 112 [24]
into which a 912 bp Hind III fragment of the 2 µM plas-
mid (nt #s105-1017) was inserted into the HindIII site.
The two FRT sites are in inverted orientation with respect
to one another. The plasmid DNA was isolated as
described previously [25]. Small-scale preparations of
plasmid DNAs were done using the QIAprep Spin Mini-
prep Kit (QIAGEN Inc, Valencia, CA, USA) or the alkaline-
iodine lysis procedure [26]. PCR fragments were purified
from agarose gels using the QIAGEN QIAquick Gel Extrac-
tion Kit. PAC DJ74K15 DNA (Accession no.90095) was
isolated from E. coli DH10B (∆(mrr-hsd RMS-mcrBC)mcrA
recA1) containing PAC DJ74K15 DNA by the alkaline lysis
method followed by phenol extraction and ethanol pre-
cipitation [27]. E. coli DNA was isolated from strain N99
(galk2, strepr) [28] and was the gift of Dr. Barbara Funnell.
Enzymes
Flp (70% pure) was purified as described [16] up to the
Sephacryl S300 step. Restriction enzymes were purchased
from New England Biolabs (Beverley, MA, USA) and were
used according to the manufacturer's instructions. Taq
DNA polymerase, PCRx enhancer and PCRx enhancer
buffer solution, MgSO4, deoxynucleoside triphosphates
and oligodeoxynulcleotide primers (see table 1) were pur-
chased from GibcoBRL(now Invitrogen, Carlsbad, CA,
USA). The primers were desalted and used without further
purification.
PCR amplification conditions
i) LacZ. The reaction mixtures (50 µl) contained 1xPCRx
Enhancer buffer, 3 mM MgSO4, 0.25 mM of each of the
four deoxynucleoside triphosphates, 4 µM of each of
primers 1 and 2, see Table 1), 100 ng of E. coli DNA and
2.5 units of Taq DNA polymerase. The cycling conditions
were: 95°, 2 min, {95°, 45 sec, 55°, 50 sec, 72°, 2 min}
repeated 30 times, 72°, 10 min, cool to 4°.
ii) KCNQ1. The reaction mixtures (50 µl) were the same
as above except contained 4 µM of each of primers 3 and
4, (Table 1) and 20 ng of PAC DJ74K15 DNA. The cycling
conditions were: 95°, 2 min, {95°, 45 sec, 60°, 45 sec,
72°, 2 min} repeated 30 times, 72°, 10 min, cool to 4°.
Agarose gel electrophoresis
Agarose gels (1.5%, w/v) were run in TAE buffer (40 mM
Tris-acetate, 1 mM EDTA, pH 8.0 [13] and stained with
ethidium bromide.
Flp double cross reactions
The reaction mixtures (10 µl) contained 50 mM Tris-Cl
buffer, pH 7.4, 33 mM NaCl, 1 mM EDTA, 100 ng (~0.15
pmol {15 nM} of symmetry elements), or 1000 ng (1.5
pmol {150 nM} symmetry elements) of plasmid substrate
and ~100 ng of PCR fragment (1.0 pmol {100 nM} of
symmetry elements for LacZ cassette; 0.375 pmol {37.5
nM} of symmetry elements for the KCNQ1 fragment) and
140 ng of S300 Flp preparation, (2 pmol of protein, 200
nM). Reactions were incubated for 30 min at 30°, heated
at 65° for 5 min and then chilled on ice. One µl aliquots
were used to transform 2-mercaptoethanol-treated com-
petent XL1-Blue cells (Stratagene).
Abbreviations
Bp-base pair(s); IPTG-isopropylthio-β-D-galactoside; nt
(s)-nucleotide(s); PCR-polymerase chain reaction; X-Gal-
5-Bromo-4-Chloro-3-Indolyl-β-D-Galactoside.
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